Oslo Cancer Cluster visited King Hussein Cancer Centre (KHCC) in Jordan this week to foster international collaboration on cancer.
Oslo Cancer Cluster, Oslo University Hospital and Ultimovacs took part in a state visit to Amman in Jordan this week. The reason behind our involvement was that we want to create more international collaboration on the development of better cancer medicines. We wished to introduce Oslo University Hospital and Ultimovacs to King Hussein Cancer Foundation (KHCF), with regards to a potential collaboration on for example cancer clinical studies and innovative cancer treatments.
Ketil Widerberg, General Manager of Oslo Cancer Cluster, spoke at the opening ceremony for the industry seminar, arranged by Innovation Norway. He emphasised that there is reason to hope in the face of cancer as a deadly disease. There are new innovative treatments, which use the immune system to treat cancer, and the use of new technology to analyze health data. If several countries cooperate with each other on data, we can discover new patterns and develop new therapies.
“We believe our countries together should bring the same urgency seen in infectious disease to cancer in the Middle East. Cancer is emerging as a major health issue in the region, and to both develop and give access to innovative treatments for cancer will be crucial in the coming years,” said Ketil Widerberg, General Manager of Oslo Cancer Cluster.
The audience included Harald V, King of Norway, Sonja, Queen of Norway, Abdullah II, King of Jordan, Rania, Queen of Jordan, Hussein, Crown Prince of Jordan, Ine Eriksen Søreide, Norwegian Foreign Minister, Iselin Nybø, Norwegian Minister of Trade, and industry representatives from the Norwegian and Jordanian delegations.
“We need global and internationally-oriented cooperation in cancer care in order to improve the lives of cancer patients. During this State Visit to Jordan, I am pleased to take part at the beginning of new and innovative partnerships between two highly innovative health and research institutions from Norway and Jordan. Jordan has the potential to serve as a hub for international partnerships in cancer care in the Middle East, and I look forward to the continuation of this partnership,” said Minister of Trade and Industry, Iselin Nybø.
During the visit, it was also discussed how Jordan can function as a power centre for better cancer treatments in the Middle East. It can potentially become a base for Norwegian relief to non-communicable diseases with an emphasis on cancer, which is an increasing cause of death in developing countries. Jordan is a relatively stable country with good infrastructure and could become a centre for a new type of Norwegian relief to the region.
A special thank you to Innovation Norway, The Norwegian Ministry of Foreign Affairs, The Norwegian Ministry of Trade and Industry, and all other organising partners involved, for making the visit a success.